Page last updated: 2024-11-04

7-hydroxyflavanone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

7-hydroxyflavanone: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

7-hydroxyflavanone : A monohydroxyflavanone that is flavanone substituted by a hydroxy group at position 7. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID1890
CHEMBL ID97542
CHEBI ID34483
SCHEMBL ID130266
MeSH IDM0165154

Synonyms (39)

Synonym
CHEMBL97542 ,
2,3-dihydro-7-hydroxy-2-phenyl-4h-1-benzopyran-4-one
CHEBI:34483 ,
7-hydroxy-2-phenyl-2,3-dihydro-4h-chromen-4-one
6515-36-2
7-hydroxyflavanone
7-hydroxyflavanone, 98%
OPREA1_401356
MLS001181922
smr000567707
LMPK12140018
HMS1664L06
bdbm50104887
H1006
7-hydroxy-2-phenyl-2,3-dihydrochromen-4-one
NCGC00246641-01
7-hydroxy-2-phenylchroman-4-one
unii-cc64495h41
cc64495h41 ,
4h-1-benzopyran-4-one, 2,3-dihydro-7-hydroxy-2-phenyl-
HMS2865F07
FT-0621433
AKOS015856572
SCHEMBL130266
J502.873F ,
7-hydroxy-flavanone
7-hydroxy-2-phenyl-4-chromanone
flavanone, 7-hydroxy-
mfcd00017487
2h-1-benzopyran-7-yloxy
41680-08-4
DTXSID0022430
7-hydroxy-2-phenyl-3,4-dihydro-2h-1-benzopyran-4-one
AS-60587
Q27116101
CS-0128374
D90988
PD039777
EX-A7837
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
monohydroxyflavanoneAny hydroxyflavanone carrying a single hydroxy substituent.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (6)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
glp-1 receptor, partialHomo sapiens (human)Potency10.00000.01846.806014.1254AID624417
BRCA1Homo sapiens (human)Potency14.12540.89137.722525.1189AID624202
P53Homo sapiens (human)Potency19.95260.07319.685831.6228AID504706
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
AromataseHomo sapiens (human)IC50 (µMol)3.80000.00001.290410.0000AID321164; AID39053
Amine oxidase [flavin-containing] AHomo sapiens (human)IC50 (µMol)13.00000.00002.37899.7700AID125224
Amine oxidase [flavin-containing] BHomo sapiens (human)IC50 (µMol)13.00000.00001.89149.5700AID125224
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (30)

Processvia Protein(s)Taxonomy
negative regulation of chronic inflammatory responseAromataseHomo sapiens (human)
steroid biosynthetic processAromataseHomo sapiens (human)
estrogen biosynthetic processAromataseHomo sapiens (human)
androgen catabolic processAromataseHomo sapiens (human)
syncytium formationAromataseHomo sapiens (human)
negative regulation of macrophage chemotaxisAromataseHomo sapiens (human)
sterol metabolic processAromataseHomo sapiens (human)
female genitalia developmentAromataseHomo sapiens (human)
mammary gland developmentAromataseHomo sapiens (human)
uterus developmentAromataseHomo sapiens (human)
prostate gland growthAromataseHomo sapiens (human)
testosterone biosynthetic processAromataseHomo sapiens (human)
positive regulation of estradiol secretionAromataseHomo sapiens (human)
female gonad developmentAromataseHomo sapiens (human)
response to estradiolAromataseHomo sapiens (human)
biogenic amine metabolic processAmine oxidase [flavin-containing] AHomo sapiens (human)
positive regulation of signal transductionAmine oxidase [flavin-containing] AHomo sapiens (human)
dopamine catabolic processAmine oxidase [flavin-containing] AHomo sapiens (human)
response to xenobiotic stimulusAmine oxidase [flavin-containing] BHomo sapiens (human)
response to toxic substanceAmine oxidase [flavin-containing] BHomo sapiens (human)
response to aluminum ionAmine oxidase [flavin-containing] BHomo sapiens (human)
response to selenium ionAmine oxidase [flavin-containing] BHomo sapiens (human)
negative regulation of serotonin secretionAmine oxidase [flavin-containing] BHomo sapiens (human)
phenylethylamine catabolic processAmine oxidase [flavin-containing] BHomo sapiens (human)
substantia nigra developmentAmine oxidase [flavin-containing] BHomo sapiens (human)
response to lipopolysaccharideAmine oxidase [flavin-containing] BHomo sapiens (human)
dopamine catabolic processAmine oxidase [flavin-containing] BHomo sapiens (human)
response to ethanolAmine oxidase [flavin-containing] BHomo sapiens (human)
positive regulation of dopamine metabolic processAmine oxidase [flavin-containing] BHomo sapiens (human)
hydrogen peroxide biosynthetic processAmine oxidase [flavin-containing] BHomo sapiens (human)
response to corticosteroneAmine oxidase [flavin-containing] BHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (13)

Processvia Protein(s)Taxonomy
iron ion bindingAromataseHomo sapiens (human)
steroid hydroxylase activityAromataseHomo sapiens (human)
electron transfer activityAromataseHomo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenAromataseHomo sapiens (human)
oxygen bindingAromataseHomo sapiens (human)
heme bindingAromataseHomo sapiens (human)
aromatase activityAromataseHomo sapiens (human)
protein bindingAmine oxidase [flavin-containing] AHomo sapiens (human)
primary amine oxidase activityAmine oxidase [flavin-containing] AHomo sapiens (human)
aliphatic amine oxidase activityAmine oxidase [flavin-containing] AHomo sapiens (human)
monoamine oxidase activityAmine oxidase [flavin-containing] AHomo sapiens (human)
flavin adenine dinucleotide bindingAmine oxidase [flavin-containing] AHomo sapiens (human)
protein bindingAmine oxidase [flavin-containing] BHomo sapiens (human)
primary amine oxidase activityAmine oxidase [flavin-containing] BHomo sapiens (human)
electron transfer activityAmine oxidase [flavin-containing] BHomo sapiens (human)
identical protein bindingAmine oxidase [flavin-containing] BHomo sapiens (human)
aliphatic amine oxidase activityAmine oxidase [flavin-containing] BHomo sapiens (human)
monoamine oxidase activityAmine oxidase [flavin-containing] BHomo sapiens (human)
flavin adenine dinucleotide bindingAmine oxidase [flavin-containing] BHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (9)

Processvia Protein(s)Taxonomy
endoplasmic reticulumAromataseHomo sapiens (human)
endoplasmic reticulum membraneAromataseHomo sapiens (human)
membraneAromataseHomo sapiens (human)
endoplasmic reticulumAromataseHomo sapiens (human)
mitochondrionAmine oxidase [flavin-containing] AHomo sapiens (human)
mitochondrial outer membraneAmine oxidase [flavin-containing] AHomo sapiens (human)
cytosolAmine oxidase [flavin-containing] AHomo sapiens (human)
mitochondrionAmine oxidase [flavin-containing] AHomo sapiens (human)
mitochondrionAmine oxidase [flavin-containing] BHomo sapiens (human)
mitochondrial envelopeAmine oxidase [flavin-containing] BHomo sapiens (human)
mitochondrial outer membraneAmine oxidase [flavin-containing] BHomo sapiens (human)
dendriteAmine oxidase [flavin-containing] BHomo sapiens (human)
neuronal cell bodyAmine oxidase [flavin-containing] BHomo sapiens (human)
mitochondrionAmine oxidase [flavin-containing] BHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (39)

Assay IDTitleYearJournalArticle
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID39053Inhibition of aromatase activity in human placental microsomes2002Bioorganic & medicinal chemistry letters, Oct-21, Volume: 12, Issue:20
Design, synthesis and evaluation of 4-imidazolylflavans as new leads for aromatase inhibition.
AID336952Inhibition of bovine thymocytes protein tyrosine kinase assessed as angiotensin 1 phosphorylation
AID1103201Antifungal activity against Fusarium equiseti (CE181) after 48 to 72 hr2004Journal of agricultural and food chemistry, Jun-02, Volume: 52, Issue:11
Antifungal chalcones and new caffeic acid esters from Zuccagnia punctata acting against soybean infecting fungi.
AID102614The compound was tested for its antiproliferative activity against MCF-7 human breast cancer cells; In active2001Bioorganic & medicinal chemistry letters, Dec-17, Volume: 11, Issue:24
Flavonoids: structural requirements for antiproliferative activity on breast cancer cells.
AID125224Inhibition of hamster liver mitochondrial monoamine oxidase MAO2001Journal of medicinal chemistry, Sep-27, Volume: 44, Issue:20
Synthesis of potential antidipsotropic isoflavones: inhibitors of the mitochondrial monoamine oxidase-aldehyde dehydrogenase pathway.
AID353303Increase in EGR1 mRNA expression in human HEK293 cells at 20 ug/mL after 6 to 12 hrs by dual-glo luciferase assay relative to control2009Bioorganic & medicinal chemistry letters, Apr-15, Volume: 19, Issue:8
Relationships between the structures of flavanone derivatives and their effects in enhancing early growth response-1 gene expression.
AID1103206Antifungal activity against Fusarium graminearum isolate CE170 after 48 to 72 hr2004Journal of agricultural and food chemistry, Jun-02, Volume: 52, Issue:11
Antifungal chalcones and new caffeic acid esters from Zuccagnia punctata acting against soybean infecting fungi.
AID1103205Antifungal activity against Fusarium graminearum isolate CE135 after 48 to 72 hr2004Journal of agricultural and food chemistry, Jun-02, Volume: 52, Issue:11
Antifungal chalcones and new caffeic acid esters from Zuccagnia punctata acting against soybean infecting fungi.
AID1103202Antifungal activity against Diaporthe longicolla CE117 after 48 to 72 hr2004Journal of agricultural and food chemistry, Jun-02, Volume: 52, Issue:11
Antifungal chalcones and new caffeic acid esters from Zuccagnia punctata acting against soybean infecting fungi.
AID429129Agonist activity at glucocorticoid receptor in human MDA-kb2 cells assessed as stimulation of luciferase activity at 100 uM by luciferase reporter gene assay2009Bioorganic & medicinal chemistry letters, Aug-15, Volume: 19, Issue:16
Effect of flavonoids on androgen and glucocorticoid receptors based on in vitro reporter gene assay.
AID34048Inhibition of hamster liver aldehyde dehydrogenase ALDH-2; No inhibition uM2001Journal of medicinal chemistry, Sep-27, Volume: 44, Issue:20
Synthesis of potential antidipsotropic isoflavones: inhibitors of the mitochondrial monoamine oxidase-aldehyde dehydrogenase pathway.
AID1103209Antifungal activity against Alternaria alternata (CE172) after 48 to 72 hr2004Journal of agricultural and food chemistry, Jun-02, Volume: 52, Issue:11
Antifungal chalcones and new caffeic acid esters from Zuccagnia punctata acting against soybean infecting fungi.
AID429128Agonist activity at androgen receptor in human MDA-kb2 cells assessed as stimulation of luciferase activity at 100 uM by luciferase reporter gene assay2009Bioorganic & medicinal chemistry letters, Aug-15, Volume: 19, Issue:16
Effect of flavonoids on androgen and glucocorticoid receptors based on in vitro reporter gene assay.
AID321164Inhibition of human aromatase in placental microsomes2008Bioorganic & medicinal chemistry, Feb-01, Volume: 16, Issue:3
New 7,8-benzoflavanones as potent aromatase inhibitors: synthesis and biological evaluation.
AID423365Binding affinity to Enterococcus faecalis KAS3 by fluorescence quenching analysis2009Journal of natural products, Apr, Volume: 72, Issue:4
Screening of flavonoids as candidate antibiotics against Enterococcus faecalis.
AID1103203Antifungal activity against Fusarium graminearum isolate CE169 after 48 to 72 hr2004Journal of agricultural and food chemistry, Jun-02, Volume: 52, Issue:11
Antifungal chalcones and new caffeic acid esters from Zuccagnia punctata acting against soybean infecting fungi.
AID1103207Antifungal activity against Macrophomina phaseolina isolate CE173 after 48 to 72 hr2004Journal of agricultural and food chemistry, Jun-02, Volume: 52, Issue:11
Antifungal chalcones and new caffeic acid esters from Zuccagnia punctata acting against soybean infecting fungi.
AID423363Antimicrobial activity against vancomycin-resistant Enterococcus faecalis after 20 hrs by broth microdilution method2009Journal of natural products, Apr, Volume: 72, Issue:4
Screening of flavonoids as candidate antibiotics against Enterococcus faecalis.
AID1103208Antifungal activity against Colletotrichum truncatum CE175 after 48 to 72 hr2004Journal of agricultural and food chemistry, Jun-02, Volume: 52, Issue:11
Antifungal chalcones and new caffeic acid esters from Zuccagnia punctata acting against soybean infecting fungi.
AID1103204Antifungal activity against Fusarium graminearum isolate CE171 after 48 to 72 hr2004Journal of agricultural and food chemistry, Jun-02, Volume: 52, Issue:11
Antifungal chalcones and new caffeic acid esters from Zuccagnia punctata acting against soybean infecting fungi.
AID423362Antimicrobial activity against Enterococcus faecalis after 20 hrs by broth microdilution method2009Journal of natural products, Apr, Volume: 72, Issue:4
Screening of flavonoids as candidate antibiotics against Enterococcus faecalis.
AID321165Inhibition of human aromatase in placental microsomes relative to aminogluthetimide2008Bioorganic & medicinal chemistry, Feb-01, Volume: 16, Issue:3
New 7,8-benzoflavanones as potent aromatase inhibitors: synthesis and biological evaluation.
AID429118Antagonist activity at glucocorticoid receptor in human MDA-kb2 cells assessed as inhibition of Dex-induced luciferase activity by luciferase reporter gene assay2009Bioorganic & medicinal chemistry letters, Aug-15, Volume: 19, Issue:16
Effect of flavonoids on androgen and glucocorticoid receptors based on in vitro reporter gene assay.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (21)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's9 (42.86)29.6817
2010's11 (52.38)24.3611
2020's1 (4.76)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 18.84

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index18.84 (24.57)
Research Supply Index3.18 (2.92)
Research Growth Index4.38 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (18.84)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other23 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]